Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...
Even treated with the most advanced therapies, patients with glioblastoma — an aggressive brain cancer — typically survive less than two years after ...